Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells
暂无分享,去创建一个
M. Maccarrone | C. Rapino | S. Trautmann | Y. Schreiber | Nicole Kämpfer-Kolb | D. Meyer zu Heringdorf | Dominique Thomas | Camilla Di Meo | Sara Standoli | A. Rudowski | Luisa Michelle Volk
[1] D. Thomas,et al. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research , 2023, Journal of mass spectrometry and advances in the clinical lab.
[2] M. Gräler,et al. The Impact of Sphingosine Kinases on Inflammation-Induced Cytokine Release and Vascular Endothelial Barrier Integrity , 2022, International journal of molecular sciences.
[3] P. Bruni,et al. The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts , 2022, International journal of molecular sciences.
[4] E. Denovan‐Wright,et al. The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma , 2022, Journal of Neuroimmunology.
[5] E. Carreira,et al. Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease , 2022, Frontiers in Pharmacology.
[6] M. Maccarrone,et al. Microglial Endocannabinoid Signalling in AD , 2022, Cells.
[7] E. Denovan‐Wright,et al. The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation , 2022, Frontiers in Pharmacology.
[8] B. Peng,et al. TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia , 2021, Cell Death & Disease.
[9] F. Schumacher,et al. Mouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile , 2021, International journal of molecular sciences.
[10] M. Maccarrone,et al. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain , 2021, Frontiers in Pharmacology.
[11] T. Bisogno,et al. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization , 2021, International journal of molecular sciences.
[12] J. Chun,et al. Lysophospholipid (S1P) receptors in GtoPdb v.2021.2 , 2021, IUPHAR/BPS Guide to Pharmacology CITE.
[13] Jeffrey A. Cohen,et al. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions , 2021, The Lancet.
[14] P. Rao,et al. Cannabinoid-induced changes in the immune system: The role of microRNAs. , 2021, International immunopharmacology.
[15] E. Sturm,et al. Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation , 2021, International journal of molecular sciences.
[16] L. McCullough,et al. The Functional Role of Sphingosine Kinase 2 , 2021, Frontiers in Molecular Biosciences.
[17] P. Clayton,et al. Palmitoylethanolamide: A Natural Compound for Health Management , 2021, International journal of molecular sciences.
[18] Samuel S. Duffy,et al. The cannabinoid system and microglia in health and disease , 2021, Neuropharmacology.
[19] S. Spiegel,et al. Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNFα‐dependent inflammation and apoptosis , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] A. Torsello,et al. Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects , 2021, International journal of molecular sciences.
[21] P. Edison,et al. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? , 2020, Nature Reviews Neurology.
[22] Y. Hannun,et al. Transcriptional Regulation of Sphingosine Kinase 1 , 2020, Cells.
[23] Justin L. Black,et al. Dissecting Gq/11-Mediated Plasma Membrane Translocation of Sphingosine Kinase-1 , 2020, Cells.
[24] J. Pfeilschifter,et al. The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives , 2020, Cells.
[25] B. Barboni,et al. Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? , 2020, Expert opinion on drug discovery.
[26] Yumin Zhang,et al. Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology , 2020, Frontiers in Neurology.
[27] T. Bisogno,et al. Cannabinoids and the expanded endocannabinoid system in neurological disorders , 2019, Nature Reviews Neurology.
[28] A. Petcherski,et al. Sphingosine kinase 2 is a negative regulator of inflammatory macrophage activation. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[29] S. Sonnino,et al. Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases , 2019, Front. Pharmacol..
[30] B. Brüne,et al. Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater , 2019, Front. Immunol..
[31] G. van Echten-Deckert,et al. Neural sphingosine 1‐phosphate accumulation activates microglia and links impaired autophagy and inflammation , 2019, Glia.
[32] D. Friedman,et al. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders , 2019, The Lancet Neurology.
[33] Yumin Zhang,et al. Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells , 2019, Cells.
[34] T. Hla,et al. Sphingosine 1-phosphate and inflammation. , 2019, International immunology.
[35] P. Morales,et al. Cannabinoid Ligands Targeting TRP Channels , 2019, Front. Mol. Neurosci..
[36] M. Ballantyne,et al. Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse , 2019, European journal of pharmacology.
[37] Eun-Kyoung Kim,et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia , 2018, Autophagy.
[38] T. Uyama,et al. Endocannabinoids and related N-acylethanolamines: biological activities and metabolism , 2018, Inflammation and regeneration.
[39] S. Hickman,et al. Microglia in neurodegeneration , 2018, Nature Neuroscience.
[40] A. Huwiler,et al. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. , 2017, Pharmacology & therapeutics.
[41] G. van Echten-Deckert,et al. Sphingosine 1-phosphate - A double edged sword in the brain. , 2017, Biochimica et biophysica acta. Biomembranes.
[42] M. Maccarrone. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years , 2017, Front. Mol. Neurosci..
[43] M. Colonna,et al. Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.
[44] H. de Vries,et al. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity , 2017, Nature Communications.
[45] Huazhen Chen,et al. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling , 2016, Journal of Neuroinflammation.
[46] Tobias Hoch,et al. Identification of the oleic acid ethanolamide (OEA) isomer cis-vaccenic acid ethanolamide (VEA) as a highly abundant 18:1 fatty acid ethanolamide in blood plasma from rats and humans , 2016, Analytical and Bioanalytical Chemistry.
[47] S. O'Sullivan,et al. An update on PPAR activation by cannabinoids , 2016, British journal of pharmacology.
[48] N. Quan,et al. Neuroinflammation: the devil is in the details , 2016, Journal of neurochemistry.
[49] K. Mackie,et al. An Introduction to the Endogenous Cannabinoid System , 2016, Biological Psychiatry.
[50] Dayong Zhang,et al. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion , 2016, Inflammation Research.
[51] Jian Cheng,et al. Sphingosine kinase 1 mediates neuroinflammation following cerebral ischemia , 2015, Experimental Neurology.
[52] Ainoa Rueda-Zubiaurre,et al. Endocannabinoids drive the acquisition of an alternative phenotype in microglia , 2015, Brain, Behavior, and Immunity.
[53] W. Santos,et al. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[54] B. Przewłocka,et al. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures , 2015, Neural plasticity.
[55] J. Leza,et al. Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats , 2015, The international journal of neuropsychopharmacology.
[56] W. Santos,et al. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors. , 2015, Journal of medicinal chemistry.
[57] M. O’Banion,et al. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed , 2014, Journal of Neuroinflammation.
[58] R. Proia,et al. Sphingosine Kinases Are Not Required for Inflammatory Responses in Macrophages* , 2013, The Journal of Biological Chemistry.
[59] P. Gressens,et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro , 2013, Brain, Behavior, and Immunity.
[60] C. Compagnucci,et al. Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells , 2013, PloS one.
[61] M. Pistis,et al. Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids , 2012, Molecular Neurobiology.
[62] P. Chameau,et al. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors , 2012, Proceedings of the National Academy of Sciences.
[63] C. Usai,et al. The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release , 2011, Cellular and Molecular Life Sciences.
[64] B. Wattenberg. Role of sphingosine kinase localization in sphingolipid signaling. , 2010, World journal of biological chemistry.
[65] F. Ginhoux,et al. Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.
[66] S. Pyne,et al. Interaction between anandamide and sphingosine‐1‐phosphate in mediating vasorelaxation in rat coronary artery , 2010, British journal of pharmacology.
[67] M. Cascio,et al. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. , 2010, Carcinogenesis.
[68] Peter Natesan Pushparaj,et al. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia , 2010, Neuroscience.
[69] A. Spagnolo,et al. Anandamide enhances IL‐10 production in activated microglia by targeting CB2 receptors: Roles of ERK1/2, JNK, and NF‐κB , 2010, Glia.
[70] K. Jakobs,et al. Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors. , 2009, Biochimica et biophysica acta.
[71] R. P. Landry,et al. Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation , 2009, Molecular pain.
[72] D. Im,et al. Characterization of N,N,-dimethyl-D-erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of sphingosine kinase inhibition. , 2008, Prostaglandins & other lipid mediators.
[73] L. Obeid,et al. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. , 2008, Prostaglandins & other lipid mediators.
[74] J. Whitaker,et al. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators , 2007, FEBS letters.
[75] P. Chomczyński,et al. The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on , 2006, Nature Protocols.
[76] J. Pfeilschifter,et al. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism. , 2006, Biochimica et biophysica acta.
[77] Daniele Piomelli,et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). , 2006, CNS drug reviews.
[78] Yun Bai,et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation , 2005, Journal of Neuroinflammation.
[79] Y. Igarashi,et al. Identification of functional nuclear export sequences in human sphingosine kinase 1. , 2003, Biochemical and biophysical research communications.
[80] A. Finazzi-Agro’,et al. Cannabimimetic Activity, Binding, and Degradation of Stearoylethanolamide within the Mouse Central Nervous System , 2002, Molecular and Cellular Neuroscience.
[81] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[82] Z. Vogel,et al. Anandamide may mediate sleep induction , 1997, Nature.
[83] J. Pfeilschifter,et al. Pharmacology of the sphingosine-1-phosphate signalling system. , 2013, Handbook of experimental pharmacology.
[84] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .